There is a mass of unstructured Real-World health related data surrounding every major healthcare Congress, some of these will be critical signals, but are you picking them up from the noise?
Join Scott Crae, Co-Founder, Partnerships and Impact, and Josh Eadsforth, Product Owner at Talking Medicines in this session on how Congress Intelligence Tracking, powered by Drug-GPT’s Advanced Data Science and AI, is helping Strategists capture the real voice of HCPs — before, during, and after congress.
Discover what real-life Consumer conversations reveal about the evolving GLP-1 journey, from dose adjustments and weight loss plateaus to discontinuation, persistence, and the branded vs compounded debate.
Quickly solving a problem. Using real-life health related data to inform strategy. Shift from planning assumptions to real-life intelligence – powered by behavior, sentiment and engagement data.
Can large language models truly support regulatory-grade pharmaceutical communication? Learn more in our recent TMLabs briefing session.